Evidence map›Paper›PMID 39341987›Full record

ArticleCommunications biology2024

Full-length single-cell BCR sequencing paired with RNA sequencing reveals convergent responses to pneumococcal vaccination.

Duncan M Morgan, Yiming J Zhang, Jin-Hwan Kim, MaryAnn Murillo, Suddham Singh, Jakob Loschko, Naveen Surendran, Ognjen Sekulovic, Ellie Feng, Shuting Shi and 5 more

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Humoral immunity in cancer.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Duncan M MorganKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0002-3253-1362
Yiming J ZhangKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0002-8102-3815
Jin-Hwan KimVaccine Research and Development Pfizer Inc. Pearl River, New York, NY, USA.
MaryAnn MurilloVaccine Research and Development Pfizer Inc. Pearl River, New York, NY, USA.
Suddham SinghVaccine Research and Development Pfizer Inc. Pearl River, New York, NY, USA.
Jakob LoschkoVaccine Research and Development Pfizer Inc. Pearl River, New York, NY, USA.
Naveen SurendranVaccine Research and Development Pfizer Inc. Pearl River, New York, NY, USA.
Ognjen SekulovicVaccine Research and Development Pfizer Inc. Pearl River, New York, NY, USA.
Ellie FengKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0009-0002-4900-4814
Shuting ShiKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.
Darrell J IrvineKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.ORCID 0000-0002-8637-1405
Sarita U PatilCenter for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Isis KanevskyVaccine Research and Development Pfizer Inc. Pearl River, New York, NY, USA.
Laurent ChorroVaccine Research and Development Pfizer Inc. Pearl River, New York, NY, USA.
J Christopher LoveKoch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA. clove@mit.edu.ORCID 0000-0003-0921-3144

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Paula T Hammond · 1985 to 2026
$93.9M
Structural and functional characterization of protective antibodies induced in peanut oral immunotherapyR01AI155630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Sarita U Patil · 2021 to 2026
$3.1M
National Cancer Center P30-CA14051NCI NIH HHS P30 CA014051NIAID NIH HHS R01 AI155630
6 · The paper itself

Abstract

Single-cell RNA sequencing (scRNA-seq) can resolve transcriptional features from individual cells, but scRNA-seq techniques capable of resolving the variable regions of B cell receptors (BCRs) remain limited, especially from widely-used 3'-barcoded libraries. Here, we report a method that can recover paired, full-length variable region sequences of BCRs from 3'-barcoded scRNA-seq libraries. We first verify this method (B3E-seq) can produce accurate, full-length BCR sequences. We then apply this method to profile B cell responses elicited against the capsular polysaccharide of Streptococcus pneumoniae serotype 3 (ST3) by glycoconjugate vaccines in five infant rhesus macaques. We identify BCR features associated with specificity for the ST3 antigen which are present in multiple vaccinated monkeys, indicating a convergent response to vaccination. These results demonstrate the utility of our method to resolve key features of the B cell repertoire and profile antigen-specific responses elicited by vaccination.

Indexed as

Macaca mulattaPneumococcal VaccinesReceptors, Antigen, B-CellSingle-Cell AnalysisStreptococcus pneumoniaeAnimalsB-LymphocytesPneumococcal InfectionsSequence Analysis, RNAVaccinationPneumococcal VaccinesReceptors, Antigen, B-Cell

Identifiers

PMID39341987
PMCPMC11438910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.